Acetaminophen/Caffeine/Aspirin

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the acute treatment of migraine in adults. It is intended for use in patients experiencing migraine attacks and should be administered as per the prescribing guidelines.

Dosage and Administration

Adults should take 2 caplets with a full glass of water. The maximum dosage should not exceed 2 caplets within a 24-hour period, unless otherwise directed by a healthcare professional. For individuals under 18 years of age, it is advised to consult a doctor prior to use. It is imperative to adhere strictly to the recommended dosage and not exceed the directed amount.

Contraindications

Use is contraindicated in patients with a history of allergic reactions to acetaminophen, aspirin, or any other pain reliever or fever reducer. Additionally, concurrent use with any other medication containing acetaminophen, whether prescription or nonprescription, is contraindicated. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

Warnings and Precautions

Children and teenagers who have or are recovering from chickenpox or flu-like symptoms should not use this product. The use of this product in these populations may pose significant health risks. If any changes in behavior accompanied by nausea and vomiting occur while using this product, it is imperative to consult a healthcare professional, as these symptoms may indicate the onset of Reye’s syndrome, a rare but serious condition.

In the event of an overdose, immediate medical assistance is essential. Individuals should seek emergency medical help or contact a Poison Control Center without delay. Prompt medical attention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Healthcare professionals should advise patients to discontinue use and consult a doctor if any of the following occur: an allergic reaction, which requires immediate medical attention; signs of stomach bleeding, including feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain; if a migraine is not alleviated or worsens after the first dose; the emergence of new or unexpected symptoms; or if there is ringing in the ears or loss of hearing. Monitoring for these symptoms is essential to ensure patient safety and effective management of potential adverse effects.

Side Effects

Patients should be aware of the potential adverse reactions associated with this product. Serious adverse reactions include the risk of Reye’s syndrome, particularly in children and teenagers who have or are recovering from chickenpox or flu-like symptoms. It is crucial for these individuals to avoid using this product. If patients experience changes in behavior accompanied by nausea and vomiting while using this product, they should consult a doctor immediately, as these symptoms may indicate the onset of Reye’s syndrome, a rare but serious condition.

Patients are advised to discontinue use and seek medical attention if they experience any signs of an allergic reaction. Additionally, they should be vigilant for symptoms indicative of stomach bleeding, which may include feeling faint, vomiting blood, passing bloody or black stools, or experiencing persistent stomach pain. If a patient’s migraine is not relieved or worsens after the first dose, or if new or unexpected symptoms arise, they should also consult a healthcare professional.

Furthermore, patients should be aware that ringing in the ears or loss of hearing may occur and should seek medical advice if these symptoms develop.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Acetaminophen Aspirin Caffeine. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients, including children and teenagers, should not use this product if they have or are recovering from chicken pox or flu-like symptoms due to the risk of Reye’s syndrome. In the event of changes in behavior accompanied by nausea and vomiting while using this product, it is important to consult a healthcare professional, as these symptoms may indicate an early sign of Reye’s syndrome. For individuals under 18 years of age, it is recommended to seek medical advice prior to use.

Geriatric Use

Elderly patients, particularly those aged 60 and older, may have an increased risk of severe stomach bleeding. Healthcare providers should exercise caution when prescribing this medication to geriatric patients, considering the potential for heightened adverse effects.

It is advisable to closely monitor elderly patients for any signs of gastrointestinal bleeding and to evaluate the necessity of dosage adjustments based on individual patient factors. Careful assessment of the risk-benefit ratio is essential when treating this population to ensure optimal safety and efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The use of aspirin during the last trimester of pregnancy is particularly concerning, as it may lead to adverse effects on fetal outcomes or complications during delivery. Therefore, it is crucial that pregnant patients only use aspirin in this period if explicitly directed by a healthcare provider.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication if they are pregnant or breastfeeding. It is particularly important to avoid the use of aspirin during the last three months of pregnancy unless explicitly directed by a healthcare provider, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.

For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.

Nonclinical Toxicology

It is especially important not to use aspirin during the last three months of pregnancy unless specifically directed by a healthcare professional, as it may lead to complications for the unborn child or during delivery. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no details regarding nonclinical toxicology or animal pharmacology and toxicology provided in the current information.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions associated with the use of acetaminophen and aspirin.

Severe skin reactions, including skin reddening, blisters, and rash, have been reported in association with acetaminophen. Additionally, severe allergic reactions, such as hives, facial swelling, asthma (wheezing), and shock, have been noted in connection with aspirin. These events were reported voluntarily or through surveillance programs and are included in the ongoing assessment of the safety profile of these medications.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose, as prompt medical attention is crucial for both adults and children, even if no signs or symptoms are apparent.

Patients should be instructed to discontinue use and consult a doctor if they experience any signs of an allergic reaction, as well as if they notice symptoms indicative of stomach bleeding, such as feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain. Additionally, if a patient's migraine is not alleviated or worsens after the first dose, they should stop use and seek medical advice.

It is important for healthcare providers to inform patients to stop use and consult a doctor if they develop new or unexpected symptoms, including ringing in the ears or loss of hearing. Patients should also be encouraged to discuss their medical history with their healthcare provider before use, particularly if they have never had migraines diagnosed by a health professional, if they experience headaches that differ from their usual migraines, or if they have the worst headache of their life.

Patients should be advised to seek medical consultation if they have a fever accompanied by a stiff neck, if headaches begin after or are caused by head injury, exertion, coughing, or bending, or if they experience their first headache after the age of 50. Those with daily headaches or migraines severe enough to require bed rest should also consult a doctor prior to use.

Healthcare providers should remind patients to discuss any liver disease, history of stomach problems such as heartburn, high blood pressure, heart disease, liver cirrhosis, or kidney disease with their doctor before using the medication. Patients taking diuretics, those with asthma, or individuals who have experienced serious side effects from pain relievers or fever reducers should also seek medical advice before use.

Furthermore, patients should be encouraged to consult a doctor or pharmacist if they are taking prescription medications for diabetes, gout, or arthritis, if they are under a doctor's care for any serious condition, or if they are taking any other drugs or products containing aspirin, acetaminophen, or any other pain reliever or fever reducer.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, maintaining a range of 20° to 25°C (68° to 77°F).

After each use, the cap must be closed tightly to ensure the integrity of the product. Healthcare professionals are advised to read all product information thoroughly before use to ensure proper handling and application.

Additional Clinical Information

The route of administration for the medication is oral. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is particularly crucial to avoid aspirin during the last three months of pregnancy unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery.

Drug Information (PDF)

This file contains official product information for Acetaminophen Aspirin Caffeine, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)